Heimo Mairbäurl Selected Research

Amiloride (Midamor)

7/2020	The role of hypoxia-induced modulation of alveolar epithelial Na+- transport in hypoxemia at high altitude.
9/2016	Inhibition of alveolar Na transport and LPS causes hypoxemia and pulmonary arterial vasoconstriction in ventilated rats.
11/2011	β2-Adrenergics in hypoxia desensitize receptors but blunt inhibition of reabsorption in rat lungs.
7/2010	Alveolar but not intravenous S-ketamine inhibits alveolar sodium transport and lung fluid clearance in rats.
1/2010	Beta2-adrenergic stimulation blunts inhibition of epithelial ion transport by hypoxia of rat alveolar epithelial cells.
11/2007	Dexamethasone prevents transport inhibition by hypoxia in rat lung and alveolar epithelial cells by stimulating activity and expression of Na+-K+-ATPase and epithelial Na+ channels.
3/2003	Nasal epithelium potential difference at high altitude (4,559 m): evidence for secretion.
4/2002	Hypoxia decreases active Na transport across primary rat alveolar epithelial cell monolayers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Heimo Mairbäurl Research Topics

Disease

31	Hypoxia (Hypoxemia) 01/2022 - 04/2002
14	Pulmonary Edema 01/2018 - 10/2002
8	Edema (Dropsy) 01/2020 - 05/2002
4	Altitude Sickness (Mountain Sickness) 01/2020 - 10/2006
4	Ischemia 11/2015 - 06/2008
3	Pulmonary edema of mountaineers 03/2011 - 01/2009
3	Pulmonary Hypertension 12/2010 - 01/2006
3	Inflammation (Inflammations) 07/2010 - 03/2005
2	Brain Edema (Cerebral Edema) 10/2021 - 01/2011
2	Hemolysis 01/2018 - 10/2013
2	Neoplasms (Cancer) 03/2016 - 12/2011
1	Rhinosinusitis 01/2021
1	Nasal Polyps (Nasal Polyp) 01/2021
1	Cystic Fibrosis (Mucoviscidosis) 01/2018
1	Colonic Neoplasms (Colon Cancer) 03/2016
1	Acute Lung Injury 01/2014
1	Lactic Acidosis 10/2013
1	Anemia 01/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2012
1	Glioblastoma (Glioblastoma Multiforme) 12/2011
1	Lung Injury 07/2010
1	Endotoxemia 07/2010
1	Pneumonia (Pneumonitis) 07/2010
1	Sepsis (Septicemia) 07/2010
1	Reperfusion Injury 03/2010
1	Infarction (Infarctions) 06/2008

Drug/Important Bio-Agent (IBA)

11	Oxygen (Dioxygen)IBA 01/2022 - 03/2003
10	Proteins (Proteins, Gene)FDA Link 07/2020 - 05/2002
8	Amiloride (Midamor)FDA LinkGeneric 07/2020 - 04/2002
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018 - 03/2005
4	Messenger RNA (mRNA)IBA 07/2020 - 11/2003
4	Adenosine Triphosphatases (ATPase)IBA 01/2016 - 01/2005
4	Adenosine Triphosphate (ATP)IBA 10/2013 - 01/2005
3	Hemoglobins (Hemoglobin)IBA 01/2018 - 01/2013
3	Terbutaline (Brethaire)FDA LinkGeneric 11/2011 - 03/2009
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2010 - 03/2005
3	Tadalafil (Cialis)FDA Link 08/2009 - 03/2005
2	Protons (Proton)IBA 10/2021 - 04/2012
2	SodiumIBA 10/2021 - 04/2006
2	ChloridesIBA 01/2021 - 04/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 08/2009
2	Free RadicalsIBA 01/2018 - 12/2010
2	HMGB1 Protein (HMG1)IBA 03/2016 - 06/2008
2	EnzymesIBA 03/2016 - 03/2010
2	EsketamineIBA 01/2014 - 07/2010
2	Lactic Acid (Lactate)FDA LinkGeneric 10/2013 - 01/2005
2	NitritesIBA 01/2009 - 03/2005
1	Erythropoietin FDA Link 01/2022
1	ElectrolytesIBA 10/2021
1	Transcription Factors (Transcription Factor)IBA 07/2020
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2020
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020
1	vasectrin IIIIBA 09/2018
1	CatalaseIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	BilirubinIBA 01/2018
1	Ferritins (Ferritin)IBA 01/2018
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2018
1	HaptoglobinsIBA 01/2018
1	lumacaftorIBA 01/2018
1	ivacaftorIBA 01/2018
1	Budesonide (Pulmicort)FDA LinkGeneric 01/2017
1	Pharmaceutical PreparationsIBA 03/2016
1	malate dehydrogenase (decarboxylating)IBA 03/2016
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 12/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2015
1	HepcidinsIBA 02/2015
1	IronIBA 02/2015
1	platelet-derived growth factor AIBA 02/2015
1	Mixed Function Oxygenases (Monooxygenases)IBA 06/2013
1	OrganophosphatesIBA 04/2012
1	Carbon DioxideIBA 04/2012
1	EpitopesIBA 12/2011
1	Biological ProductsIBA 12/2011
1	CatecholaminesIBA 03/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2011
1	LipopolysaccharidesIBA 07/2010
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 03/2010
1	Small Interfering RNA (siRNA)IBA 03/2010
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2010
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 08/2009
1	IodocyanopindololIBA 03/2009
1	Cholera ToxinIBA 03/2009
1	ColforsinIBA 03/2009
1	Endothelin-1 (Endothelin 1)IBA 01/2009
1	AlbuminsIBA 01/2009
1	Minoxidil (Rogaine)FDA LinkGeneric 01/2006
1	NitratesIBA 03/2005
1	Adenine FDA LinkGeneric 01/2005
1	iberiotoxinIBA 06/2004
1	TeaIBA 06/2004
1	Carrier Proteins (Binding Protein)IBA 11/2003
1	Salmeterol Xinafoate (Serevent)FDA Link 10/2002
1	CytokinesIBA 05/2002
1	EicosanoidsIBA 05/2002

Therapy/Procedure

1	Therapeutics 01/2018
1	Microspheres (Microsphere) 03/2005